Modernising Part B (human tissue products) of the Prescribed List

Learn about the proposed reforms to Part B of the Prescribed List.

What the reform is about

We are modernising Part B in line with the changes to the rest of the Prescribed List.

How we will achieve this

There are two initiatives to modernise Part B:

  1. Revise the classification structure;
  2. Introduce health technology assessment for human tissue products.

We have and will continue to work with relevant stakeholders to progress this reform measure.

Timeline

We have published stakeholder feedback analysis report. This report captures stakeholder feedback and our response to each of the 10 recommendations on the PricewaterhouseCoopers’ final report.

Please note the use of previous terminology – Prostheses List/prostheses.

We aim to implement each recommendation before the end of the PL reform period.

Past activities

DateActivity
August 2023 – October 2023 Consulted on the recommendations in the PwC final report
August 2023Published initial departmental response to PwC recommendations in the final report
May 2023PwC delivered a final report, including 10 key recommendations to support the proposed reforms to Part B of the PL
February 2023 – March 2023PwC consulted with key Part B stakeholders via two workshops
December 2022Engaged PwC to review Consultation Paper 2(a) and stakeholder feedback
January 2022 – March 2022Consulted on ways to modernise Part B Consultation Paper 2(a) – Modernisation of Part B of the Prostheses List
Date last updated:

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.